Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 (Perampanel) Phase 2 in Refractory Epilepsy
NCT03780907Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2003
- Primary completion
- Aug 2003
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perampanel in epilepsy, sponsored by Eisai Co., Ltd.. Started Feb 2003; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03780907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780907.